CTT Pharma's Scientists Publish Peer-Reviewed Paper in the Journal of Drug Delivery and Therapeutics
Rhea-AI Summary
CTT Pharma (OTCQB:CTTH) announced on December 16, 2025 that a peer‑reviewed paper was published in the journal Drug Delivery and Therapeutics by Dr. Katharine Cole and Dr. Pankaj Modi.
The review describes how micellar nanotechnology combined with an oral dissolvable strip delivery system can improve delivery and bioavailability of active therapeutic compounds. The company says the article is the first comprehensive scientific review on this combined approach.
The publication is available in the company's Scientific Publications section at www.cttpharmaceuticals.com and the company indicates additional peer‑reviewed articles will be added as available.
Positive
- None.
Negative
- None.
News Market Reaction
On the day this news was published, CTTH gained 6.91%, reflecting a notable positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
TAMPA, FL / ACCESS Newswire / December 16, 2025 / (OTCQB:CTTH) CTT Pharmaceutical Holdings, Inc. is pleased to announce that a peer-reviewed scientific paper has been published in the journal of Drug Delivery and Therapeutics, authored by our scientist Dr. Katharine Cole and Dr. Pankaj Modi, the founder of CTT Pharma. The article provides the first comprehensive scientific review describing how micellar nanotechnology, when combined with an oral dissolvable strip delivery system, can significantly improve the delivery and bioavailability of active therapeutic compounds. "This review article is an important step forward in bringing wider scientific attention to this innovative and transformative technology," said Dr. Cole.
This publication is available on the Company's website www.cttpharmaceuticals.com in the 'Scientific Publications' section. This section includes peer-reviewed articles authored by CTT scientists that contribute to the broader scientific literature in areas relevant to the company's scientific focus. These publications are provided solely for transparency and informational purposes. Additional publications will be added as they become available.
CTT Pharma
813-606-0060
SOURCE: CTT Pharmaceutical Holdings, Inc.
View the original press release on ACCESS Newswire
FAQ
What did CTTH publish on December 16, 2025?
Where can investors read the CTTH peer‑reviewed paper published December 16, 2025?
What is the paper's main finding about micellar nanotechnology and oral dissolvable strips?
Who authored the CTTH December 2025 publication?
Will CTT Pharma publish more peer‑reviewed articles on its website?
